Brief: Resonance Health Says Hepafatsmart Cleared By US FDA
29/06/2023 02:24
June 29 (Reuters) - Resonance Health Ltd RHT.AX :
* UPDATED HEPAFATSMART CLEARED BY US FDA
* RECEIVED REGULATORY CLEARANCE FROM US FDA TO MARKET
HEPAFATSMART
Source text for Eikon: ID:nASXb97HcC
Further company coverage: RHT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Resonance Health
See all newsBrief: Resonance Health Halts Trading In Resonance Health Securities Pending Announcement
Australia's Resonance Health gains on IAG agreement
Brief: Resonance Health Enters Global Strategic Alliance & MSA With Image Analysis Group
Brief: Resonance Health Posts Profit Attributable Of A$1.5 Million
Brief: Resonance Health Says It Expects FY27 Normalised EBITDA Of AUD 2.6 To 3.6 Million